Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RASCAS: A2AR in Hypercholesterolemia
NCT05017649Recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Sep 2021
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoints: Quantification of A2AR expression in PBMCs and Quantification of A2AR function in PBMC. Started Sep 2021; status: recruiting.
Beyond the preview
Go deeper on NCT05017649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05017649.